- Home
- KSCP vs FGEN Comparison
KSCP vs FGEN Comparison
Compare KSCP & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- FGEN
- Stock Information
- Founded
- KSCP 2013
- FGEN 1993
- Country
- KSCP United States
- FGEN United States
- Employees
- KSCP N/A
- FGEN N/A
- Industry
- KSCP Telecommunications Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- KSCP Telecommunications
- FGEN Health Care
- Exchange
- KSCP Nasdaq
- FGEN Nasdaq
- Market Cap
- KSCP 29.3M
- FGEN 33.5M
- IPO Year
- KSCP 2022
- FGEN 2014
- Fundamental
- Price
- KSCP $5.08
- FGEN $0.31
- Analyst Decision
- KSCP Strong Buy
- FGEN Strong Buy
- Analyst Count
- KSCP 2
- FGEN 1
- Target Price
- KSCP $10.50
- FGEN $10.00
- AVG Volume (30 Days)
- KSCP 461.0K
- FGEN 899.4K
- Earning Date
- KSCP 05-15-2025
- FGEN 05-05-2025
- Dividend Yield
- KSCP N/A
- FGEN N/A
- EPS Growth
- KSCP N/A
- FGEN N/A
- EPS
- KSCP N/A
- FGEN N/A
- Revenue
- KSCP $10,805,000.00
- FGEN $29,621,000.00
- Revenue This Year
- KSCP $27.04
- FGEN $232.81
- Revenue Next Year
- KSCP $41.79
- FGEN $9.16
- P/E Ratio
- KSCP N/A
- FGEN N/A
- Revenue Growth
- KSCP N/A
- FGEN N/A
- 52 Week Low
- KSCP $2.45
- FGEN $0.18
- 52 Week High
- KSCP $28.57
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- KSCP 61.64
- FGEN 46.92
- Support Level
- KSCP $4.41
- FGEN $0.27
- Resistance Level
- KSCP $5.70
- FGEN $0.31
- Average True Range (ATR)
- KSCP 0.55
- FGEN 0.03
- MACD
- KSCP 0.41
- FGEN 0.01
- Stochastic Oscillator
- KSCP 80.92
- FGEN 81.38
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.